Eventide Asset Management’s Natus Medical Inc NTUS Stock Holding History

Eventide Asset Management’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-75,000	Closed	-$2.87M	–	151
2017 Q4	$2.87M	Hold	75,000	–	–	0.15%	97
2017 Q3	$2.81M	Hold	75,000	–	–	0.16%	93
2017 Q2	$2.8M	Hold	75,000	–	–	0.17%	88
2017 Q1	$2.94M	Hold	75,000	–	–	0.19%	86
2016 Q4	$2.61M	Hold	75,000	–	–	0.17%	90
2016 Q3	$2.95M	Hold	75,000	–	–	0.18%	86
2016 Q2	$2.83M	Hold	75,000	–	–	0.17%	87
2016 Q1	$2.88M	Sell	75,000 -73,900	-50%	-$2.75M	0.16%	93
2015 Q4	$7.16M	Buy	148,900 +12,900	+9%	+$597K	0.36%	68
2015 Q3	$5.37M	Buy	136,000 +61,000	+81%	+$2.59M	0.31%	72
2015 Q2	$3.19M	Hold	75,000	–	–	0.17%	87
2015 Q1	$2.96M	Hold	75,000	–	–	0.22%	87
2014 Q4	$2.7M	Hold	75,000	–	–	0.3%	71
2014 Q3	$2.21M	Hold	75,000	–	–	0.31%	68
2014 Q2	$1.89M	Buy	75,000 +3,900	+5%	+$96.4K	0.26%	77
2014 Q1	$1.83M	Buy	71,100 +40,300	+131%	+$1.02M	0.28%	73
2013 Q4	$693K	Buy	+30,800	New	+$595K	0.21%	70

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

VCM

Voce Capital Management San Francisco, California $57.8M AUM 9.28% 1-Year Est. Return

Eventide Asset Management's NTUS Position: Q1 2018 in Review

Eventide Asset Management sold out of Natus Medical Inc (NTUS) in Q1 2018, closing a stake of 75,000 shares — an estimated $2.87M sold.

Eventide Asset Management first reported a position in NTUS in Q4 2013 and held it in 17 quarters. The position peaked at $7.16M in Q4 2015. 184 funds tracked by Wall St. Rank hold NTUS as of Q1 2018.

Eventide Asset Management reported no remaining Natus Medical Inc position as of Q1 2018 after selling out during the quarter.
Eventide Asset Management sold 75,000 Natus Medical Inc shares in Q1 2018, an estimated $2.87M.
Eventide Asset Management first reported a position in Natus Medical Inc in Q4 2013 and held it in 17 quarters.
Eventide Asset Management's Natus Medical Inc position peaked at $7.16M in Q4 2015.
184 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2018.

Based on Eventide Asset Management's 13F filing for Q1 2018, filed 15 May 2018.